Sofianne Gabrielli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sofianne Gabrielli has a total of 535 co-authors. Here are the top co-authors by number of shared publications:
Moshe Ben-Shoshan
Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Centre, Montreal, QC, Canada
22 shared publicationsXun Zhang
Division of Allergy and Clinical Immunology, Department of Pediatrics Montreal Children's Hospital, McGill University Health Centre Montreal Quebec Canada
14 shared publicationsEdmond S. Chan
Division of Allergy and Immunology, Department of Pediatrics, British Columbia Children's Hospital University of British Columbia Vancouver British Columbia Canada
12 shared publicationsElena Netchiporouk
McGill University Health Centre
11 shared publicationsHarley Eisman
Department of Emergency Medicine Montreal Children's Hospital McGill University Health Centre Montreal QC Canada
10 shared publicationsJudy Morris
Department of Emergency Medicine, Sacré-Coeur Hôpital, Montreal, Quebec, Canada
10 shared publications
Latest Publications
- Open Access
- 31 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1258
Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma
Localized scleroderma (LS) is an autoimmune, fibrotic skin disease that is thought to be triggered by environmental factors. Recent evidence from systemic autoimmune diseases proposed that the induction of immunosenescence may link environmental triggers with autoimmunity development. We aimed to explore the inflammatory signature in juvenile LS and investigate the presence of DNA instability and immunosenescence using publicly available transcriptomic data. High-throughput RNA sequencing data from 28 juvenile LS and 10 healthy controls were analyzed. Unsupervised clustering, pathway analyses, cell-type enrichment, fusion analyses, and immunosenescence gene set enrichment were performed. IFN and Type 1/2/3 pathways were upregulated in clinically active and histologically inflammatory LS. Type 2 inflammatory signature in both inflammatory and fibrotic LS was demonstrated by enriched genes, pathways, and deconvolution analyses (eosinophils). Features of genotoxic stress signals manifesting as DNA instability genes, pathways, and fusion events as well as mitochondrial dysfunction were demonstrated for the first time in LS. Features of immunosenescence (e.g., the upregulation of pathways involved in T cell exhaustion, inhibitory receptors, and cellular senescence and the enrichment of senescent genes) were also confirmed in (active and inflammatory) LS. Immunosenescence and inflammaging may underlie the complex and heterogeneous nature of immune responses seen in LS and should be further studied.
- 31 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1258
Open AccessMarkers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma
Localized scleroderma (LS) is an autoimmune, fibrotic skin disease that is thought to be triggered by environmental factors. Recent evidence from systemic autoimmune diseases proposed that the induction of immunosenescence may link environmental triggers with autoimmunity development. We aimed to explore the inflammatory signature in juvenile LS and investigate the presence of DNA instability and immunosenescence using publicly available transcriptomic data. High-throughput RNA sequencing data from 28 juvenile LS and 10 healthy controls were analyzed. Unsupervised clustering, pathway analyses, cell-type enrichment, fusion analyses, and immunosenescence gene set enrichment were performed. IFN and Type 1/2/3 pathways were upregulated in clinically active and histologically inflammatory LS. Type 2 inflammatory signature in both inflammatory and fibrotic LS was demonstrated by enriched genes, pathways, and deconvolution analyses (eosinophils). Features of genotoxic stress signals manifesting as DNA instability genes, pathways, and fusion events as well as mitochondrial dysfunction were demonstrated for the first time in LS. Features of immunosenescence (e.g., the upregulation of pathways involved in T cell exhaustion, inhibitory receptors, and cellular senescence and the enrichment of senescent genes) were also confirmed in (active and inflammatory) LS. Immunosenescence and inflammaging may underlie the complex and heterogeneous nature of immune responses seen in LS and should be further studied.
- 9 January 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
The impact of the COVID-19 pandemic on patients with nonmalignant and malignant dermatologic conditions
- 9 January 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
The impact of the COVID-19 pandemic on patients with nonmalignant and malignant dermatologic conditions
- Open Access
- 9 October 2024
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 55 (1) , 94-96
Anaphylaxis Management in Paediatric Patients Undergoing Milk Oral Immunotherapy
- 9 October 2024
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 55 (1) , 94-96
Open AccessAnaphylaxis Management in Paediatric Patients Undergoing Milk Oral Immunotherapy
- 11 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (1) , 156-164.e4
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges
- 11 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (1) , 156-164.e4
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges
- 26 May 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (10) , 1059-1061
Duration of skin prick test refractory period following food‐induced allergic reactions
- 26 May 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (10) , 1059-1061
Duration of skin prick test refractory period following food‐induced allergic reactions
- Top Cited PapersOpen Access
- 17 February 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , 1490-1520
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
Alopecia areata (AA) is a common inflammatory autoimmune disease of the hair which can have a significant negative impact on quality of life (QoL), mental health and productivity. The aim of this scoping review is to elucidate the burden of AA focusing on these three realms. Inclusion criteria included all original manuscripts with no restriction on study type or statistical method written in English (or having an English abstract). For QoL 40 articles were included, 85 for psychiatric comorbidities, and 9 for work/school absenteeism/presenteeism mostly consisting of cross‐sectional and observational cohort studies. QoL impairment was detected in over 75% of patients and up to one‐third reported extremely severe QoL impairments. Specific QoL dimensions with the greatest impact were embarrassment, social functioning, as well as shopping and/or housework. Cross‐sectional studies assessing the psychological burden of adult patients with AA found that the presence of signs of anxiety and/or depression ranged from 30% to 68% and affected all age groups. Rates of work absenteeism and unemployment were significantly higher in AA patients compared to healthy controls. Up to 62% reported making major life decisions including relationships, education and career based on their AA. Additionally, the extensive camouflage techniques and time lost from work led to a strong financial burden for patients and the numerous physician visits added to the healthcare costs. The overall impact of AA stretches much further than simply being an aesthetic concern and can negatively impact every part of an individual's life. An individualized approach and effective treatments will help reduce the psychosocial consequences and distress and return patients to their normal state of health.
- 17 February 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , 1490-1520
Top Cited PapersOpen AccessThe burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
Alopecia areata (AA) is a common inflammatory autoimmune disease of the hair which can have a significant negative impact on quality of life (QoL), mental health and productivity. The aim of this scoping review is to elucidate the burden of AA focusing on these three realms. Inclusion criteria included all original manuscripts with no restriction on study type or statistical method written in English (or having an English abstract). For QoL 40 articles were included, 85 for psychiatric comorbidities, and 9 for work/school absenteeism/presenteeism mostly consisting of cross‐sectional and observational cohort studies. QoL impairment was detected in over 75% of patients and up to one‐third reported extremely severe QoL impairments. Specific QoL dimensions with the greatest impact were embarrassment, social functioning, as well as shopping and/or housework. Cross‐sectional studies assessing the psychological burden of adult patients with AA found that the presence of signs of anxiety and/or depression ranged from 30% to 68% and affected all age groups. Rates of work absenteeism and unemployment were significantly higher in AA patients compared to healthy controls. Up to 62% reported making major life decisions including relationships, education and career based on their AA. Additionally, the extensive camouflage techniques and time lost from work led to a strong financial burden for patients and the numerous physician visits added to the healthcare costs. The overall impact of AA stretches much further than simply being an aesthetic concern and can negatively impact every part of an individual's life. An individualized approach and effective treatments will help reduce the psychosocial consequences and distress and return patients to their normal state of health.
- Open Access
- 13 August 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (12) , 3293-3298.e2
Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria
- 13 August 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (12) , 3293-3298.e2
Open AccessValidation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria
- 8 March 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (7) , 1927-1929.e1
Validation of UAS7 among children with chronic spontaneous urticaria
- 8 March 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (7) , 1927-1929.e1
Validation of UAS7 among children with chronic spontaneous urticaria
- 3 March 2022
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (3) , e13751
Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history
Background: Cold urticaria (coldU) is associated with substantial morbidity and risk of fatality. Data on coldU in children are sparse. We aimed to evaluate the clinical characteristics, management, risk of associated anaphylaxis, and resolution rate of coldU in a pediatric cohort. Additionally, we sought to compare these metrics to children with chronic spontaneous urticaria (CSU).Methods: We prospectively enrolled children with coldU from 2013–2021 in a cohort study at the Montreal Children's Hospital and an affiliated allergy clinic. Data for comparison with participants with solely CSU were extracted from a previous study. Data on demographics, comorbidities, severity of presentation, management, and laboratory values were collected at study entry. Patients were contacted yearly to assess for resolution.Results: Fifty‐two children with cold urticaria were recruited, 51.9% were female and the median age of symptom onset was 9.5 years. Most patients were managed with second‐generation H1‐antihistamines (sgAHs). Well‐controlled disease on sgAHs was negatively associated with concomitant CSU (adjusted odds ratio (aOR) = 0.69 [95%CI: 0.53, 0.92]). Elevated eosinophils were associated with cold‐induced anaphylaxis (coldA; aOR = 1.38 [95%CI: 1.04, 1.83]), which occurred in 17.3% of patients. The resolution rate of coldU was 4.8 per 100 patient‐years, which was lower than that of CSU (adjusted hazard ratio = 0.43 [95%CI: 0.21, 0.89], p < 10−2).Conclusion: Pediatric coldU bears a substantial risk of anaphylaxis and a low‐resolution rate. Absolute eosinophil count and co‐existing CSU may be useful predictive factors.
- 3 March 2022
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (3) , e13751
Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history
Background: Cold urticaria (coldU) is associated with substantial morbidity and risk of fatality. Data on coldU in children are sparse. We aimed to evaluate the clinical characteristics, management, risk of associated anaphylaxis, and resolution rate of coldU in a pediatric cohort. Additionally, we sought to compare these metrics to children with chronic spontaneous urticaria (CSU).Methods: We prospectively enrolled children with coldU from 2013–2021 in a cohort study at the Montreal Children's Hospital and an affiliated allergy clinic. Data for comparison with participants with solely CSU were extracted from a previous study. Data on demographics, comorbidities, severity of presentation, management, and laboratory values were collected at study entry. Patients were contacted yearly to assess for resolution.Results: Fifty‐two children with cold urticaria were recruited, 51.9% were female and the median age of symptom onset was 9.5 years. Most patients were managed with second‐generation H1‐antihistamines (sgAHs). Well‐controlled disease on sgAHs was negatively associated with concomitant CSU (adjusted odds ratio (aOR) = 0.69 [95%CI: 0.53, 0.92]). Elevated eosinophils were associated with cold‐induced anaphylaxis (coldA; aOR = 1.38 [95%CI: 1.04, 1.83]), which occurred in 17.3% of patients. The resolution rate of coldU was 4.8 per 100 patient‐years, which was lower than that of CSU (adjusted hazard ratio = 0.43 [95%CI: 0.21, 0.89], p < 10−2).Conclusion: Pediatric coldU bears a substantial risk of anaphylaxis and a low‐resolution rate. Absolute eosinophil count and co‐existing CSU may be useful predictive factors.